OTC vaginal yeast infections self-treated by 45% of women -- Prevention survey.
This article was originally published in The Tan Sheet
Executive Summary
OTC VAGINAL YEAST INFECTION MEDICATIONS USED BY 45% OF WOMEN first, making them as likely to treat themselves as to consult a physician, according to the results of a Prevention magazine nationwide telephone survey of 1,200 adults 18 and older. "Probably due in large part to the number of medications for this condition that have recently switched from prescription to over-the-counter status, the proportion of women who treat themselves first increased from 38% to 45% during the past year," the magazine says. "Now women are just as likely to treat themselves for yeast infections as they are to consult a physician -- a marked difference in behavior from last year when women were more likely consult their doctor first," the survey notes.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: